Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ARCA biopharma Inc. logo

ARCA biopharma Inc.

Sector: Healthcare   

Industry: Biotechnology

1.76
 
USD
  
0.01
  
(0.57%)
Optionable: Yes  Market Cap: 25 M  90-day average vol: 26,680

Previous close: 1.75  Open: 1.76  Bid: 1.71  Ask: 1.8
52 week range    
1.56   
   2.16
Peers   
CYTK / 
PTN / 
BTX / 
MDT / 
Last updated: Friday 29th March 2024
49
MarketXLS Rank
60
Value
46
Technical
42
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ABIO Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in other current assets-331000.02000.0-479000.0437000.0689000.0401000.0-348000.0-156000.0808000.093000.0
(Increase) Decrease in other current liabilities2000.0-3000.0-9000.0
(Increase) Decrease in other working capital2000.0-12000.0-6000.06000.0
(Increase) Decrease in payables198000.0-431000.0841000.0-583000.0-392000.0188000.01 M-411000.0-783000.028000.0
Amortization of intangibles71000.0
CapitalExpenditureReported19000.011000.012000.03000.04000.04000.019000.043000.02000.0
Cash at beginning of period17 M15 M39 M7 M9 M7 M8 M49 M53 M42 M
Cash at end of period15 M39 M7 M9 M7 M8 M49 M53 M42 M37 M
Cash flow-9 M-11 M-15 M-17 M-8 M-5 M-8 M-19 M-11 M-5 M
CashFlowFromContinuingInvestingActivities-19000.0-11000.0-16 M13 M3 M-4000.0-19000.0-43000.0-2000.0
ChangeInAccountPayable198000.0-431000.0841000.0-583000.0-392000.0188000.01 M-411000.0-783000.028000.0
ChangeInAccruedExpense-182000.0196000.0-3000.0193000.0-298000.0-127000.0450000.0435000.0-934000.0-526000.0
ChangeInInterestPayable-182000.0196000.0-3000.0193000.0-298000.0-127000.0450000.0435000.0
ChangeInPayablesAndAccruedExpense16000.0-235000.0838000.0-390000.0-690000.061000.02 M24000.0-2 M-498000.0
ChangeInWorkingCapital-313000.0-236000.0350000.047000.0-1000.0462000.01 M-138000.0-909000.0-399000.0
CommonStockPayments-2 M-977000.0
Depreciation12000.019000.024000.027000.022000.018000.08000.016000.020000.015000.0
Depreciation unreconciled79000.0208000.0481000.0475000.024000.089000.093000.091000.0114000.0111000.0
DepreciationAndAmortization79000.0208000.0481000.0475000.024000.089000.093000.091000.0114000.0111000.0
FinancingCashFlow8 M34 M6 M3 M7 M48 M23 M
Free cash flow-9 M-11 M-15 M-17 M-8 M-5 M-8 M-19 M-11 M-5 M
GainLossOnSaleOfPPE5000.0
InterestPaidSupplementalData3000.04000.06000.08000.07000.09000.0
Issuance of capital stock9 M37 M7 M4 M7 M51 M24 M
Issuance of debt-179000.0-193000.0-256000.0-311000.0-349000.0-408000.0
IssuanceOfCapitalStock9 M37 M7 M4 M7 M51 M24 M
IssuanceOfDebt-179000.0-193000.0-256000.0-311000.0-349000.0-408000.0
Net cash from financing activities8 M34 M6 M3 M7 M48 M23 M
Net cash from investing activities-19000.0-11000.0-16 M13 M3 M-4000.0-19000.0-43000.0-2000.0
Net cash from operating activities-9 M-11 M-15 M-17 M-8 M-5 M-8 M-19 M-11 M-5 M
Net change in cash & cash equivalents-1 M23 M-31 M1 M-2 M2 M41 M4 M-11 M-5 M
Net income from continuing operations-10 M-11 M-16 M-18 M-8 M-5 M-10 M-19 M-10 M-5 M
NetCommonStockIssuance9 M37 M7 M4 M7 M49 M23 M
NetInvestmentPropertiesPurchaseAndSale-16 M13 M3 M
NetInvestmentPurchaseAndSale-16 M13 M3 M
NetIssuancePaymentsOfDebt-179000.0-193000.0-256000.0-311000.0-349000.0-408000.0
NetPPEPurchaseAndSale-19000.0-11000.0-12000.0-3000.0-4000.0-4000.0-19000.0-43000.0-2000.0
Operating (gains) losses-130000.0340000.050000.038000.0-607000.0-21000.0686000.0110000.0-747000.0-73000.0
Other financing charges net-836000.0-3 M-448000.0-117000.0-372000.0-2 M-977000.0
Other non-cash items647000.0599000.0576000.0458000.0273000.0151000.043000.0497000.0556000.0686000.0
PensionAndEmployeeBenefitExpense-130000.0340000.050000.038000.0-607000.0-21000.0686000.0110000.0-752000.0-73000.0
Purchase of Float term investments-21 M-5 M
Purchase of property plant & equipment-19000.0-11000.0-12000.0-3000.0-4000.0-4000.0-19000.0-43000.0-2000.0
PurchaseOfInvestment-21 M-5 M
PurchaseOfPPE-19000.0-11000.0-12000.0-3000.0-4000.0-4000.0-19000.0-43000.0-2000.0
RepaymentOfDebt-179000.0-193000.0-256000.0-311000.0-349000.0-408000.0
Repurchase of capital stock-2 M-977000.0
Revenue per share67000.0189000.0457000.0448000.02000.071000.085000.075000.094000.096000.0
Sale of short term investments4 M18 M3 M
SaleOfInvestment4 M18 M3 M
ShortTermDebtPayments-179000.0-193000.0-256000.0-311000.0-349000.0-408000.0
StockBasedCompensation647000.0599000.0576000.0458000.0273000.0151000.043000.0497000.0556000.0686000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University